Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Deferred Tax Liability (2016 - 2025)

Conmed (CNMD) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $74.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability rose 13.73% year-over-year to $74.9 million, compared with a TTM value of $74.9 million through Sep 2025, up 13.73%, and an annual FY2024 reading of $74.1 million, up 21.63% over the prior year.
  • Non-Current Deferred Tax Liability was $74.9 million for Q3 2025 at Conmed, up from $69.8 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $112.6 million in Q3 2022 and bottomed at $56.6 million in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $70.2 million, with a median of $66.1 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability skyrocketed 91.0% in 2022, then crashed 40.56% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $68.5 million in 2021, then decreased by 2.64% to $66.7 million in 2022, then fell by 8.73% to $60.9 million in 2023, then increased by 21.63% to $74.1 million in 2024, then rose by 1.05% to $74.9 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for CNMD at $74.9 million in Q3 2025, $69.8 million in Q2 2025, and $70.0 million in Q1 2025.